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Toxic Shock-like Syndrome Associated with Necrotizing Streptococcus 
Pyogenes Infection 
Thomas J. Connolly,* Donald J. Pavelka, MD,^  Eugene F. Lanspa, MD, 
and Thomas L . Connolly, MD' 
Two patients with toxic shock-like syndrome are presented. Bolh patients had necrotizing cellulitis due 
to Streptococcus pyogenes, and both patients required extensive surgical debridement. The 
association of Streptococcus pyogenes infection and toxic shock-like syndrome is discussed. (Henry 
Ford Hosp MedJ 1989:37:69-72) 
S ince 1978, toxin-producing strains of Staphylococcus aureus have been implicated as the cause of the toxic shock 
syndrome (TSS), which is characterized by fever and rash and 
followed by desquamation, hypotension, and multisystem in-
volvement (1). Most cases subsequently reported have occurred 
in menstruadng women in association with tampon use (2-6). 
However, TSS associated with Staphylococcus aureus infection 
has been described in numerous other clinical illnesses includ-
ing use of contraceptive sponges (7), nasal packing (8,9), sur-
gical wound infection (10), and nonsurgical infections at various 
sites including skin and subcutaneous tissue (11,12). 
Cone et al (13) recently described a toxic shock-like illness in 
two patients with cellulitis due to group A beta-hemolytic strep-
tococci (Streptococcus pyogenes). Several other reports have im-
plicated Streptococcus pyogenes in TSS (14-16). 
Two patients with necrotizing Streptococcus pyogenes infec-
tions associated with a toxic shock-like syndrome have been ob-
served at our hospital in the past three years. These padents were 
admitted with streptococcal cellulitis with prominent necrosis of 
skin and subcutaneous tissue which required extensive surgical 
debridement to control the illness. One ofthe patients was also 
bacteremic with Streptococcus pyogenes. We report these cases 
to increase the awareness that Streptococcus pyogenes may pro-
duce a toxic shoek-like syndrome and that aggressive surgical 
treatment may be necessary to obtain an optimal result. 
brought to the emergency room where a physical examination revealed 
a temperature of 40.9°C (I05.6°F), blood pressure of 98/72 mm Hg, 
respiration of 36 breaths/min, and a pulse of 72 beats/min. The skin 
showed a bright sunburn-type rash, most prominent over the trunk and 
face, but present over the entire body. Desquamation of skin ofthe up-
per and lower extremities, particularly the hands and feet, occurred 
later A strawberry tongue was present, and there was prominent infec-
tion of both bulbar and palpebral conjunctivae. A 3 x 3 cm abrasion was 
noted over the right elbow. The surrounding skin was indurated, 
erythematous, and tender Vesicles were present (Figure). The abraded 
area oozed serous drainage. The patient became more hypotensive, and 
a Swan-Ganz catheter was inserted for hemodynamic monitoring. In-
travenous crystaloid infusions, albumin, and dopamine were admin-
istered to maintain adequate blood pressure. He received 2 g of nafcillin 
intravenously every six hours for 48 hours and subsequently 6 mU of 
penicillin intravenously every 24 hours for 19 days. He also received 
500 mg of inctronidazole intravenously every six hours from days 3 
through 16 and I g of cefoperazone intravenously every 12 hours from 
days 3 through 13. He developed a rapidly rising creatinine (424 ixmol/ 
L [4.8 mg/dL] on admission), abnormal liver function, renal failure, 
and acute respiratory distress syndrome. Hemodialysis and ventilatory 
support were given. Blood cultures and cultures of drainage from the 
elbow area revealed Streptococcus pyogenes. The organism produced 
pyrogenic streptococcal type B toxin but not toxins A and C.§ His con-
dition was further complicated by colonic distention, gastrointestinal 
bleeding due to gastritis, and cardiac arrhythmias. He developed 
rapidly progressive necrotic changes of the skin and subcutaneous 
tissue of the right arm and forearm, accompanied by hemorrhagic 
Case Reports 
Casel 
A 76-year-old man suffered a superficial abrasion of his right elbow 
two days prior to admission. He was being treated with chlorthalidone 
and metropolol for hypertension but otherwise had been in good health. 
He was not diabetic. Over a two-day period the elbow area became pro-
gressively more erythematous, tender, and swollen. He was visited at 
home by a nurse who noted that he was confused and severely il l . He 
was noted to have a bright erythroderma over most of his body. He was 
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Table 
Laboratory Values in Two Patients with Streptococcal 
Necrotizing Cellulitis and Toxic Shock Syndrome 
Case 1 Case 2 
12/15/87 12/18/87 4/29/86 5/1/86 
WBC count (per |xL) 11.0 14.6 21.4 14.6 
Hemoglobin (g/dL) 17.6 12.8 11.8 10.4 
Hematocrit (%) 53.7 36.2 35.4 30.8 
Platelet count (per JJLL) 193 48 248 170 
Creatinine 
|j.mol/L (mg/dL) 424 (4.8) 813(9.2) 566 (6.4) 194(2.2) 
BUN 
mmol/L (mg/dL) 15.7(44) 38.2(107) 24.9 (70) 17.9 (50) 
Bilirubin 
IJtmol/L (mg/dL) 27(1.6) 72 (4.2) 67 (3.9) 123 (7.2) 
Alkaline phosphatase 
M-kat/L (U/L) 0.4 (22) 0.8 (45) 4.4 (261) 2.6(153) 
SCOT* 
|xkat/L (U/L) 1.40 (84) 13.94(836) 0.63 (38) 0.62 (37) 
CPKt 2,417 2.386 319 509 
Albumin 
g/L (g/dL) 29(2.9) 32(3.2) 30 (3.0) 30 (3.0) 
Calcium 
mmol/L (g/dL) 2.20(8.8) 1.60(6.4) 1.87 (7.5) 1.77 (7.1) 
*SGOT denotes aspartate aminotransferase. 
tCPK denotes creatinine phosphokinase. 
Figure—Dorsum of forearm with cellulitis with bleb formation. 
bullae. These changes required repeated extensive surgical debride-
ment over a three-week period following admission. The infection was 
ultimately controlled, and skin grafting was performed prior to the 
patient's discharge from the hospital. Laboratory data are listed in 
the Table. 
Case 2 
A 22-year-old nulliparous woman noted erythema and tenderness of 
the right breast 72 hours prior to admission. She was obese but other-
wise had been in excellent health. She was not diabetic. Her breast had 
not been injured. She had completed a normal menstrual period one 
week previously. She had not used tampons and had not been sexually 
active. She had not had any vaginal irritation or discharge. Twenty-four 
hours after her initial symptoms, she developed some vesiculation of 
the skin. She was seen by her physician who prescribed 500 mg of 
cephalexin every six hours. She developed some nausea and diarrhea 
the following day. Two days after antibiotics were started, she devel-
oped rapidly increasing erythema, swelling and induration ofthe 
breast, with necrosis ofthe skin and subcutaneous tissue with extensive 
eschar formation. She was noted to be confused and was brought to the 
hospital. Physical examination revealed an acutely ill woman. Her tem-
perature was 38.9°C (I02°F), blood pressure 90/70 mm Hg, and pulse 
100 beats/min. She was confused. There was diffuse erythroderma of 
the skin of the trunk and extremities resembling a sunburn. There was 
considerable erythema, induration, and necrosis of the skin of the right 
breast. Extensive blister formation was also present. Desquamation of 
skin ofthe hands occurred later Bulbar and palpebral conjunctival in-
fection and a strawberry tongue were present. Muscles of the upper and 
lower extremities were markedly tender to palpation. She received 2 g 
of nafcillin intravenously every four hours for nine days and 900 mg of 
clindamycin intravenously every eight hours for three days. She was 
given an initial dose of 2 mg/kg of tobramycin intravenously with sub-
sequent doses being adjusted for dysfunction. She received tobramycin 
for nine days. Although her .serum creatinine initially was 566 pimol/L 
(6.4 mg/dL), dialysis was not necessary. Cultures from several areas of 
the inflamed breast grew Streptococcus pyogenes. Streptococcal 
pyrogenic toxin determinations were not performed, and the strep-
tococcal isolate is not available. Cultures of the breast also revealed 
Pseudomonas aeruginosa and Enterobacter cloacae. Vaginal cultures 
K\e.n\c(i Escherichia coh, Pseudomonas aeruginosa, and Candida al-
bicans. Blood and urine cultures were negative. 
Extensive surgical debridement of skin and subcutaneous tissue of 
the breast was performed, with skin grafting to the breast accomplished 
later Laboratory data are noted in the Table. 
Discussion 
Streptococcus pyogenes may cause numerous infections in-
cluding pharyngitis, cellulitis, impedgo, erysipelas, puerperal 
fever, and bacteremia, as well as necrotizing cellulitis, fasciids, 
or myosins. It may also be responsible for noninfectious i l l -
nesses including rheumatic fever, glomerulonephritis, and 
erythema nodosa. While Streptococcus pyogenes may produce 
toxins A, B, and C, recently type A toxin has been produced by 
far fewer strains than in previous years (17). Streptococcal tox-
ins have diverse toxic properdes that include pyrogenicity, en-
hancement of lethal endotoxin effects, and increased vascular 
permeability and skin reactivity, as seen in scariet fever (18-21). 
Willoughby and Greenberg (22) noted that Streptococcus 
pyogenes produced toxins with biologic features in common 
with toxins associated with staphylococcal TSS and suggested 
that these streptococcal toxins might also cause a toxic shock-
like syndrome. Toxic shock syndrome toxin-I (TSST-1) (23-26), 
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previously termed staphylococcal enterotoxin F or pyrogenic 
exotoxin C, and staphylococcal enterotoxin B (27,28) are 
considered to be the staphylococcal products responsible for 
staphylococcal TSS. 
It has been noted that streptococcal toxin A and staphylococ-
cal toxin B are related structurally (29). 
Both of our patients manifested symptoms characteristic of 
staphylococcal toxic shock. These features included diffuse 
erythroderma, conjunctival infecdon, strawberry tongue, hypo-
tension, both hepatic and renal dysfunction, and desquamation 
of the skin. 
The patient in Case 1 was bacteremic with Streptococcus 
pyogenes. His rash was that of a bright erythroderma and not the 
typical sandpaper rash of scarlet fever Prominent conjunctival 
infection, strawberry tongue, and hepatic dysfunction were 
present. These features and the severe renal dysfunction requir-
ing dialysis that occurred with mild hypotension strongly sug-
gested a toxic shock-like syndrome rather than effects of strep-
tococcal bacteremia. Both padents rapidly developed extensive 
necrotic changes of skin and subcutaneous dssue. Extensive sur-
gical debridement was performed early in the course of both pa-
tients; repeated surgical debridement was required in Case 1. For 
this patient in pardcular, the effectiveness of debridement ap-
peared to be correlated with clinical improvement, with clinical 
deterioration occurring when further necrosis of tissue 
developed. 
The degree of skin involvement, mucous membrane man-
ifestations, and deg ree of tissue destruction in this syndrome 
have been quite varied. Hribalova (15) reported a case of peri-
tonids with rash but no mucous membrane involvement. Two of 
the three cases described by Bartter et al (14) had erythroderma, 
but mucous membrane involvement and tissue destrucdon were 
not noted. Desquamation was noted in one patient. Both cases 
described by Cone et al (13) had erythema of the face and con-
junctivids, but a strawberry tongue was not noted. Desquama-
tion did not occur, and tissue destruction was not noted. Tissue 
destruction was a prominent feature of the 20 cases described by 
Stevens et al (16), but generalized erythema was not noted. Two 
of their cases had a petechial rash, and two had maculopapular 
rash. Four of their patients had desquamadon. These authors 
emphasized the role of erythrogenic toxin type A in their cases. 
Eight of the ten strains of Streptococcus pyogenes produced 
pyrogenic exotoxin A, three produced toxins A and B, one pro-
duced toxins A, B, and C, and one produced only toxin B. 
Both of our cases had prominent erythroderma followed by 
desquamadon, conjunctivids, and strawberry tongue. Both also 
had prominent tissue destruction requiring extensive debride-
ment. In Case 1 where tissue destruction was most marked, toxin 
analysis revealed the presence of exotoxin B but not toxins A or 
C. In a recent editorial, Stollerman (30) noted that all three 
erythrogenic toxins, types A, B, and C, of Streptococcus 
pyogenes possessed potent toxin properties with type A being 
the most potent. It is thus not surprising that TSS due to Strep-
tococcus pyogenes may be associated with both toxins A and B 
and possibly toxin C as well, although type A appears to be the 
most prevalent. 
It is important to recognize that TSS may be associated with 
various Streptococcus pyogenes infections, some clinically ob-
vious and some occult, and that patients with prominent tissue 
destruction requiring extensive debridement comprise an impor-
tant group of these infections. 
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